Pfizer
Trade Pfizer 24 hours a day, five days a week on Robinhood.
Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.About PFE
Pfizer Inc. is a research-based global biopharmaceutical company, which engages in the discovery, development, manufacture, marketing, sales and distribution of biopharmaceutical products worldwide. The firm works across developed and emerging markets to advance wellness, prevention, treatments and cures that challenge the most feared diseases.
PFE Key Statistics
Stock Snapshot
As of today, Pfizer(PFE) shares are valued at $28.30. The company's market cap stands at 161.09B, with a P/E ratio of 20.89 and a dividend yield of 6.1%.
During the trading session on 2026-04-04, Pfizer(PFE) shares reached a daily high of $28.75 and a low of $28.22. At a current price of $28.30, the stock is +0.3% higher than the low and still -1.5% under the high.
Trading volume for Pfizer(PFE) stock has reached 30.92M, versus its average volume of 40.76M.
Over the past 52 weeks, Pfizer(PFE) stock has traded between a high of $28.75 and a low of $20.92.
Over the past 52 weeks, Pfizer(PFE) stock has traded between a high of $28.75 and a low of $20.92.
PFE News
Pfizer and Valneva recently reported that their investigational 6‑valent OspA-based Lyme disease vaccine achieved more than 70% efficacy in a completed Phase 3...
England’s National Health Service announced on Thursday that three million more older adults in the country will be eligible to receive Pfizer’s (PFE) respirato...
Pfizer is closing its South San Francisco research site and office and shifting affected roles to remote work. The move is part of a broader cost cutting effor...
Analyst ratings
55%
of 29 ratingsMore PFE News
The companies confirmed they had notified the U.S. Food and Drug Administration (FDA) of their decision. The study aimed to enroll between 25,000 and 30,000 in...
A court in Belgium ordered Poland and Romania to accept the delivery of €1.9B ($2.2B) worth of COVID-19 vaccines developed by Pfizer (PFE) and BioNTech (BNTX) i...
Pfizer’s PFE stock has been trading steadily above its 50-day and 200-day simple moving averages (SMAs) since early January, signaling sustained investor confid...
Wedbush analyst David Nierengarten lowered the firm’s price target on Oric Pharmaceuticals (ORIC) to $17 from $20 and keeps an Outperform rating on the shares....
Pfizer (PFE) is back in focus after reporting over 70% efficacy in a Phase 3 Lyme disease vaccine trial and positive Phase 3 results for prostate cancer therapy...
A big dividend can’t hide the growth problem at Pfizer (PFE), one of the world’s largest pharmaceutical companies. Pfizer has seen its stock rise more than 16%...
It is not surprising that before an earnings season, every investor looks for stocks that can beat market expectations. This is because investors always try to...
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.